Hot Products

Cannabiscitrin
Catalog No: CFN95278

Cannabisin A
Catalog No: CFN95287

Cannabisin B
Catalog No: CFN95268

Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease. It induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cell.

Cannabisin D
Catalog No: CFN90405

Cannabisin D is a natural product from Cannabis sativa L.

Cannabisin F
Catalog No: CFN97809

Melongenamides B-D and Cannabisin F have anti-inflammatory activity, they exhibit inhibitions of nitric oxide production in lipopolysaccharide-induced RAW 264.7 macrophages with IC50 values ranging from 16.2 to 58.5 uM.

Cannabisin H
Catalog No: CFN94001

Reference standards.

Cannabisin M
Catalog No: CFN95436

Canniprene
Catalog No: CFN97198

Canniprene has anti-inflammatory activity, it can potently inhibit the production of inflammatory eicosanoids via the 5-lipoxygenase pathway (IC50=0.4uM) and also can affect the generation of prostaglandins via the cyclooxygenase/microsomal prostaglandin E2 synthase pathway (IC50 =10 uM).

Cantharidin
Catalog No: CFN99790

Cantharidin, a natural toxicant of blister beetles, is a strong inhibitor of protein phosphatases types 1 (PP1) and 2A (PP2A), and is a novel and potent multidrug resistance (MDR) reversal agent. Cantharidin has anti-tumor activity, it causes oxidative stress that provokes DNA damage and p53-dependent apoptosis, it impairs cell migration and invasion by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways.

Canthin-6-one
Catalog No: CFN98730

Canthin-6-one has antimicrobial, cytotoxic, antiproliferative and proapoptotic effects, possibly by interfering with the G2/M transition; it also has antiinflammatory activity by interfering with the transcription factors NF-κB and AP-1 at transcriptional level.